The study of intestinal flora and the gut–brain axis can potentially reveal novel diagnostic biomarkers for AD [17, 20, 22], but there is conflicting evidence regarding the relationship between the ApoE ε4 polymorphism and the gut microbiome profile. Here, APOE is linked to Alzheimer disease.